Impact of Hemodilution on Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia

被引：0
|
作者：
Tettero, Jesse [1 ,2 ]
Heidinga, Maaike [1 ]
Mocking, Tim [1 ]
Kelder, Angele [1 ]
Scholten, Willemijn [1 ]
Snel, Alexander [1 ]
Ngai, Lok Lam [1 ]
Bachas, Costa [1 ]
van de Loosdrecht, Arjan [1 ]
Ossenkoppele, Gert [1 ]
de Leeuw, David [1 ]
Janssen, Jeroen [3 ]
Cloos, Jacqueline [1 ]
机构：
[1] Amsterdam UMC, Amsterdam, Netherlands
[2] Virginia Tech, FBRI Canc Res Ctr, Washington, DC USA
[3] Radboudumc, Nijmegen, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
AML; acute myeloid leukemia; hemodilution; measurable residual disease; MRD;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-348
引用
收藏
页码：S307 / S308
页数：2
相关论文
共 50 条
  • [1] Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemia
    Tettero, Jesse M.
    Heidinga, Maaike E.
    Mocking, Tim R.
    Fransen, Glenn
    Kelder, Angele
    Scholten, Willemijn J.
    Snel, Alexander N.
    Ngai, Lok Lam
    Bachas, Costa
    van de Loosdrecht, Arjan A.
    Ossenkoppele, Gert J.
    de Leeuw, David C.
    Cloos, Jacqueline
    Janssen, Jeroen J. W. M.
    LEUKEMIA, 2024, 38 (03) : 630 - 639
  • [2] Monitoring Measurable/Minimal Residual Disease in Acute Myeloid Leukemia: Multiparametric Flow Cytometry-Based Approach
    Tembhare, Prashant Ramesh
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2023, 44 (06) : 554 - 565
  • [3] Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling
    Ganzel, Chezi
    Sun, Zhuoxin
    Baslan, Timour
    Zhang, Yanming
    Gonen, Mithat
    Abdel-Wahab, Omar, I
    Racevskis, Janis
    Garrett-Bakelman, Francine
    Lowe, Scott W.
    Fernandez, Hugo F.
    Ketterling, Rhett
    Luger, Selina M.
    Litzow, Mark
    Lazarus, Hillard M.
    Rowe, Jacob M.
    Tallman, Martin S.
    Levine, Ross L.
    Paietta, Elisabeth
    LEUKEMIA RESEARCH, 2022, 123
  • [4] Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry
    Tettero, Jesse M.
    Dakappagari, Naveen
    Heidinga, Maaike E.
    Oussoren-Brockhoff, Yvonne
    Hanekamp, Diana
    Pahuja, Anil
    Burns, Kerri
    Kaur, Pavinder
    Alfonso, Zeni
    van Der Velden, Vincent H. J.
    te Marvelde, Jeroen G.
    Hobo, Willemijn
    Slomp, Jennichjen
    Bachas, Costa
    Kelder, Angele
    Nguyen, Kevin
    Cloos, Jacqueline
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (06) : 426 - 439
  • [5] Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia
    Azenkot, Tali
    Jonas, Brian A.
    CANCERS, 2022, 14 (15)
  • [6] Measurable residual disease in acute myeloid leukemia using flow cytometry: approaches for harmonization/standardization
    Schuurhuis, Gerrit J.
    Ossenkoppele, Gert J.
    Kelder, Angele
    Cloos, Jacqueline
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (12) : 921 - 935
  • [7] Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia
    Roehnert, Maximilian A.
    Kramer, Michael
    Schadt, Jonas
    Ensel, Philipp
    Thiede, Christian
    Krause, Stefan W.
    Buecklein, Veit
    Hoffmann, Joerg
    Jaramillo, Sonia
    Schlenk, Richard F.
    Roellig, Christoph
    Bornhaeuser, Martin
    McCarthy, Nicholas
    Freeman, Sylvie
    Oelschlaegel, Uta
    von Bonin, Malte
    LEUKEMIA, 2022, 36 (09) : 2208 - 2217
  • [8] Measurable Residual Disease Analysis by Flow Cytometry: Assay Validation and Characterization of 385 Consecutive Cases of Acute Myeloid Leukemia
    Jum'ah, Husam A.
    Otteson, Gregory E.
    Timm, Michael M.
    Weybright, Matthew J.
    Shi, Min
    Horna, Pedro
    Jevremovic, Dragan
    Reichard, Kaaren K.
    Olteanu, Horatiu
    CANCERS, 2025, 17 (07)
  • [9] Clinical Use of Measurable Residual Disease in Acute Myeloid Leukemia
    Roug, Anne Stidsholt
    Ommen, Hans Beier
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (04)
  • [10] Clinical validation of a 10-color flow cytometry panel to detect measurable residual disease in acute myeloid leukemia
    Ikoma-Colturato, Maura R. V.
    Severino, Alef Rafael
    Tosi, Juliana Fernanda dos Santos
    Bertolucci, Camila Marques
    Cuoco, Yeda Midori Nakamura
    de Mattos, Ederson Roberto
    Colturato, Iago
    Silva, Fernanda Barbieri Rodrigues
    de Souza, Mair Pedro
    Simione, Anderson Joao
    Colturato, Vergilio Antonio Rensi
    LEUKEMIA RESEARCH, 2024, 140
12345